Karol Suppan

The effect of double dose of omeprazole on the course of angina pectoris and treadmill stress test in patients with coronary artery disease — A randomised, double-blind, placebo controlled, crossover trial

Jacek Budzyński, Maria Kłopocka, Grzegorz Pułkowski et al. · International Journal of Cardiology · 2007 · 21 citations

Medicine, Cardiology, Pharmacology +9

Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease

Radosław Wieczór, Grażyna Gadomska, Barbara Ruszkowska-Ciastek et al. · Journal of Zhejiang University SCIENCE B · 2015 · 20 citations · Full text

Medicine, Endocrinology, Internal Medicine +16

Overweight and obesity versus concentrations of VEGF-A, sVEGFR-1, and sVEGFR-2 in plasma of patients with lower limb chronic ischemia

Radosław Wieczór, Anna Maria Wieczór, Grażyna Gadomska et al. · Journal of Zhejiang University SCIENCE B · 2016 · 20 citations · Full text

Medicine, Molecular Medicine, Vascular Surgery +7

Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey

Jacek Budzyński, Grzegorz Pułkowski, Karol Suppan et al. · Health and Quality of Life Outcomes · 2011 · 15 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Suppression of gastric acid production may improve the course of angina pectoris and the results of treadmill stress test in patients with coronary artery disease.

Maciej Świątkowski, Jacek Budzyński, Maria Kłopocka et al. · PubMed · 2004 · 12 citations

Medicine, Cardiology, Pharmacology +14